There is currently not enough evidence to support the theory that expectorant medication, which is usually used to clear mucus from the airway, can help reduce the mortality rate among COVID-19 patients, the Central Epidemic Command Center (CECC) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.59%
10/14/2026 01:46 PM - Business
CPC to invest up to US$4.4 billion in Alaska LNG project
10/14/2026 01:39 PM - Politics
Ex-U.S. national intelligence director praises Han Kuang reforms
10/14/2026 01:27 PM - Politics
Emissions cuts key to Taiwan's future business orders: President
10/14/2026 01:17 PM - Sports
WBC outfielder Stuart Fairchild to visit Taiwan in November
10/14/2026 12:15 PM